ANIK - Anika Therapeutics, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Bedford,
United States
Type: Equity
ANIK price evolution
ANIK
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $62.82 | $68.63 | $72.87 | |
| Short term investments | ||||
| Net receivables | $28.36 | $33.77 | $32.08 | $35.96 |
| Inventory | $39.63 | $51.46 | $49.41 | $46.39 |
| Total current assets | $136.11 | $155 | $158.96 | $163.31 |
| Long term investments | ||||
| Property, plant & equipment | $71.78 | $75.45 | $74.24 | $74.97 |
| Goodwill & intangible assets | $11.32 | $11.7 | $12.2 | |
| Total noncurrent assets | $107.66 | $104.78 | $107.32 | |
| Total investments | ||||
| Total assets | $231.41 | $262.65 | $263.74 | $270.63 |
| Current liabilities | ||||
| Accounts payable | $6.8 | $9.99 | $10.02 | $9.86 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $25.49 | $26.12 | $28.46 | $31.06 |
| Long term debt | $25.79 | $26.34 | $26.9 | |
| Total noncurrent liabilities | $26.2 | $26.75 | $27.31 | |
| Total debt | $25.79 | $26.34 | $26.9 | |
| Total liabilities | $51.54 | $52.32 | $55.21 | $58.37 |
| Shareholders' equity | ||||
| Retained earnings | $93.53 | $123.45 | $123.54 | $128.05 |
| Other shareholder equity | -$5.7 | -$6.42 | -$6.32 | -$5.94 |
| Total shareholder equity | $210.34 | $208.54 | $212.26 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $72.87 | $86.33 | $94.39 | $95.82 |
| Short term investments | $2.5 | |||
| Net receivables | $35.96 | $34.63 | $29.84 | $24.1 |
| Inventory | $46.39 | $39.77 | $36.01 | $46.21 |
| Total current assets | $163.31 | $169.55 | $168.53 | $177.38 |
| Long term investments | ||||
| Property, plant & equipment | $74.97 | $78.97 | $68.56 | $73.23 |
| Goodwill & intangible assets | $12.2 | $81.94 | $90.16 | $99.57 |
| Total noncurrent assets | $107.32 | $179.58 | $179.01 | $188.22 |
| Total investments | $2.5 | |||
| Total assets | $270.63 | $349.13 | $347.54 | $365.61 |
| Current liabilities | ||||
| Accounts payable | $9.86 | $9.07 | $7.63 | $8.98 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $31.06 | $27.91 | $29.8 | $36.87 |
| Long term debt | $26.9 | $28.82 | $19.24 | $20.88 |
| Total noncurrent liabilities | $27.31 | $35.65 | $30.66 | $56.34 |
| Total debt | $26.9 | $28.82 | $19.24 | $20.88 |
| Total liabilities | $58.37 | $63.56 | $60.45 | $93.2 |
| Shareholders' equity | ||||
| Retained earnings | $128.05 | $210.72 | $225.58 | $221.44 |
| Other shareholder equity | -$5.94 | -$6.44 | -$5.72 | -$4.54 |
| Total shareholder equity | $212.26 | $285.56 | $287.08 | $272.4 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $38.75 | $41.92 | $40.52 | $42.97 |
| Cost of revenue | $14.56 | $15.89 | $16.64 | |
| Gross Profit | $1.44 | $27.36 | $24.63 | $26.33 |
| Operating activities | ||||
| Research & development | $7.4 | $8.16 | $7.58 | |
| Selling, general & administrative | $19.81 | $21.53 | $20.34 | |
| Total operating expenses | $26.36 | $27.2 | $29.69 | $90.11 |
| Operating income | $0.16 | -$5.06 | -$63.78 | |
| Income from continuing operations | ||||
| EBIT | $0.76 | -$5.06 | -$65.52 | |
| Income tax expense | $2.31 | $0.84 | $0.04 | -$0.2 |
| Interest expense | $0.41 | -$0.59 | -$2.31 | |
| Net income | ||||
| Net income | -$29.92 | -$0.09 | -$4.51 | -$63 |
| Income (for common shares) | -$0.09 | -$4.51 | -$63 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $166.66 | $156.24 | $147.79 | $130.46 |
| Cost of revenue | $63.57 | $62.66 | $64.85 | $61.43 |
| Gross Profit | $103.09 | $93.58 | $82.94 | $69.03 |
| Operating activities | ||||
| Research & development | $32.69 | $28.18 | $27.33 | $23.43 |
| Selling, general & administrative | $95.85 | $84.79 | $74.1 | $60.06 |
| Total operating expenses | $190.73 | $112.98 | $101.42 | $126.01 |
| Operating income | -$87.64 | -$19.4 | -$18.48 | -$56.99 |
| Income from continuing operations | ||||
| EBIT | -$87.64 | -$18.75 | $2.62 | -$28.32 |
| Income tax expense | -$2.66 | -$3.89 | -$1.71 | -$4.64 |
| Interest expense | -$2.31 | $0.19 | $0.3 | |
| Net income | ||||
| Net income | -$82.67 | -$14.86 | $4.13 | -$23.98 |
| Income (for common shares) | -$82.67 | -$14.86 | $4.13 | -$23.98 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$0.09 | -$4.51 | -$63 | |
| Operating activities | ||||
| Depreciation | $4.2 | $0.89 | $4.17 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.89 | $3.59 | $3.81 | |
| Total cash flows from operations | -$1.07 | -$0.13 | $3.64 | |
| Investing activities | ||||
| Capital expenditures | -$3.4 | -$1.81 | -$1.84 | |
| Investments | ||||
| Total cash flows from investing | -$7.03 | -$3.4 | -$1.81 | -$1.84 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.91 | $0.02 | $0.34 | |
| Net borrowings | ||||
| Total cash flows from financing | -$7.38 | -$1.11 | -$2.27 | $0.34 |
| Effect of exchange rate | $0.08 | -$0.22 | -$0.03 | $0.08 |
| Change in cash and equivalents | -$10.5 | -$5.81 | -$4.24 | $2.22 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$82.67 | -$14.86 | $4.13 | -$23.98 |
| Operating activities | ||||
| Depreciation | $16.45 | $16.34 | $16.02 | $14.99 |
| Business acquisitions & disposals | -$0.48 | -$94.6 | ||
| Stock-based compensation | $15.24 | $14.31 | $11.09 | $5.39 |
| Total cash flows from operations | -$1.79 | $4.41 | $8.4 | $13.06 |
| Investing activities | ||||
| Capital expenditures | -$5.43 | -$7.49 | -$5.14 | -$1.63 |
| Investments | $2.5 | $24.96 | ||
| Total cash flows from investing | -$5.43 | -$7.49 | -$3.12 | -$71.26 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$4.17 | $0.68 | $1.13 | $1.52 |
| Net borrowings | -$0.28 | -$0.2 | -$0.56 | |
| Total cash flows from financing | -$6.32 | -$4.85 | -$6.78 | -$3.77 |
| Effect of exchange rate | $0.08 | -$0.13 | $0.07 | $0.33 |
| Change in cash and equivalents | -$13.46 | -$8.06 | -$1.43 | -$61.65 |
News
Fundamentals
| Market cap | $241.33M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 14.80M |
| Revenue | $164.17M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$97.52M |
| Revenue Q/Q | -6.54% |
| Revenue Y/Y | 0.52% |
| P/E ratio | -2.47 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.47 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$6.59 |
|---|---|
| ROA | -37.93% |
| ROE | N/A |
| Debt/Equity | 0.27 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 5.34 |
| Quick ratio | 3.78 |